KESAVAN PATTENA SANKARAMANGALAM

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease GREENVILLE, NC NPI 1164909693

General Payments — all program years on this page

$2,434.39

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 37
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,564.13 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Grant $1,063.301
Food and Beverage $500.8316

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $259.725
2023 $610.5415
2024 $1,564.1317

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078854718 Janssen Scientific Affairs, LLC $22.77 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087203067 Novartis Pharmaceuticals Corporation $20.42 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087203069 Novartis Pharmaceuticals Corporation $22.09 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087203071 Novartis Pharmaceuticals Corporation $16.10 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087203073 Novartis Pharmaceuticals Corporation $18.04 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087203075 Novartis Pharmaceuticals Corporation $19.24 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092361248 Boston Scientific Corporation $1,063.30 01/05/2024 Grant Undisputed 01/23/2026 View at CMS
1108581705 Novo Nordisk Inc $19.19 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108582709 Novo Nordisk Inc $116.73 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111697842 Amgen Inc. $18.56 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116861816 Medtronic, Inc. $77.40 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116861818 Medtronic, Inc. $17.22 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117675093 Amgen Inc. $27.66 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117675095 Amgen Inc. $22.80 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139912531 SANOFI-AVENTIS U.S. LLC $16.53 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154878186 Kiniksa Pharmaceuticals International, plc $31.48 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154878204 Kiniksa Pharmaceuticals International, plc $34.60 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.